 Anika Therapeutics, Inc. NASDAQ: ANIK, a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid HA technology platform, today announced that Cheryl R. Blanchard, Ph.D., has been named President and Chief Executive Officer, 